Benitec Biopharma Inc. (BNTC) (CIK 0001808898) (BNTC)
Activity window: Nov. 12, 2025 to Nov. 11, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Nov. 11, 2026. Latest filing activity: Apr. 3, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Apr. 3, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has completed its review of Benitec Biopharma Inc.'s Form 10-K for the fiscal year ended June 30, 2025. The correspondence emphasizes that the responsibility for the accur… | Read Filing EDGAR |
| Mar. 20, 2026 | CORRESP | Neutral/Informational | Low | Benitec Biopharma Inc. has responded to a comment letter from the SEC regarding their Form 10-K for the fiscal year ended June 30, 2025. The SEC noted that the audit report from B… | Read Filing EDGAR |
| Feb. 24, 2026 | UPLOAD | Concern from SEC | High | The SEC has issued a comment letter to Benitec Biopharma Inc. regarding their Form 10-K for the fiscal year ended June 30, 2025. The primary concern is the omission of the signatu… | Read Filing EDGAR |
| Feb. 6, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Benitec Biopharma Inc. that they will not review the company's registration statement filed on January 30, 2026. The letter emphasizes that the respons… | Read Filing EDGAR |
| Feb. 6, 2026 | CORRESP | Neutral/Informational | Moderate | Benitec Biopharma Inc. has submitted a request to the SEC for the acceleration of the effective date of its Registration Statement on Form S-3. The company aims for the registrati… | Read Filing EDGAR |